[시장보고서]체외 대장암 스크리닝 검사 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 검사 유형별(분변잠혈 검사, 바이오마커 검사, CRC DNA 스크리닝 검사), 지역별, 경쟁별(2020-2030년)

체외 대장암 스크리닝 검사 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 검사 유형별(분변잠혈 검사, 바이오마커 검사, CRC DNA 스크리닝 검사), 지역별, 경쟁별(2020-2030년)

In-vitro Colorectal Cancer Screening Tests Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Test Type (Fecal Occult Blood Tests, Biomarker Tests, CRC DNA Screening Tests), By Region, Competition, 2020-2030F

상품코드 : 1881808

리서치사 : TechSci Research

발행일 : 2025년 11월

페이지 정보 : 영문 180 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,676,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 8,160,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,869,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 체외 대장암 스크리닝 검사 시장은 2024년 8억 9,089만 달러에서 2030년까지 10억 6,998만 달러로, CAGR 3.1%로 성장할 것으로 예측됩니다.

체외 대장암 스크리닝 검사는 대변이나 혈액 등의 생체 샘플을 이용한 진단 절차로 대장암 또는 그 전조 병변을 검출하는 것으로, 치료 성과 향상에 필수적인 질환을 조기에 발견할 수 있게 합니다. 시장 성장은 주로 전 세계 대장암 유병률의 증가와 조기 발견 방법에 대한 인식이 높아짐에 따라 주도되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	8억 9,089만 달러
시장 규모 : 2030년	10억 6,998만 달러
CAGR : 2025-2030년	3.1%
가장 빠르게 성장하는 부문	분변잠혈 검사
최대 시장	북미

주요 시장 촉진요인

전 세계적으로 증가하는 대장암 발생률은 체외진단 검사 시장의 가장 중요한 촉진제입니다. 특히 젊은 층의 신규 확진자 증가는 접근이 용이하고 정확한 진단 도구에 대한 공중보건의 시급한 필요성을 강조하고 있습니다.

주요 시장 과제

보험금 지급 정책의 불일치와 고도의 진단 기술에 따른 고비용은 세계 대장암 체외진단 검사 시장 확대에 큰 장벽으로 작용하고 있습니다. 이러한 경제적 장벽은 특히 보험 적용 범위가 불일치하거나 많은 자부담이 필요한 경우, 다양한 의료 시스템에서 환자들이 고도의 선별 검사를 받을 수 있는 기회를 제한하고 있습니다.

주요 시장 동향

맞춤형 의료 접근법의 통합이 진행되고 있는 것은 대장암 검진에 있어 중요한 추세입니다. 이를 통해 개인의 유전자 프로파일과 위험요인에 기반한 맞춤형 전략을 수립할 수 있습니다. 특정 바이오마커를 이용한 표적화된 조기 발견을 촉진합니다.

영문목차

The Global In-vitro Colorectal Cancer Screening Tests Market will grow from USD 890.89 Million in 2024 to USD 1069.98 Million by 2030 at a 3.1% CAGR. In-vitro colorectal cancer screening tests involve diagnostic procedures utilizing biological samples like stool or blood to detect colorectal cancer or its precursors, thereby enabling early disease identification crucial for improved treatment outcomes. The market's growth is primarily driven by the increasing global prevalence of colorectal cancer and heightened awareness regarding early detection methods.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 890.89 Million
Market Size 2030	USD 1069.98 Million
CAGR 2025-2030	3.1%
Fastest Growing Segment	Fecal Occult Blood Tests
Largest Market	North America

Key Market Drivers

The escalating global incidence of colorectal cancer represents a paramount driver for the in-vitro screening tests market. The increasing number of new cases, particularly among younger individuals, highlights a pressing public health demand for accessible and accurate diagnostic tools. This growing disease burden necessitates expanded screening to enable early detection, which is vital for enhancing patient survival and reducing mortality. According to the American Cancer Society, in January 2024, their annual report, "Cancer Statistics, 2024", indicated that colorectal cancer became the leading cause of cancer death in men and the second in women under 50 years old. This escalating incidence directly stimulates demand for improved in-vitro screening methods.

Key Market Challenges

Variable reimbursement policies and the high costs associated with advanced diagnostic technologies present a significant impediment to the expansion of the global in-vitro colorectal cancer screening tests market. These financial barriers restrict patient access to advanced screening options across diverse healthcare systems, particularly when insurance coverage is inconsistent or requires substantial out-of-pocket payments. This directly leads to lower adoption rates, as both healthcare providers and individuals may prioritize more affordable or covered alternatives, even if they are less comprehensive.

Key Market Trends

The growing integration of personalized medicine approaches is a significant trend in colorectal cancer screening, enabling tailored strategies based on individual genetic profiles and risk factors. This facilitates targeted early detection through specific biomarkers. According to the American Cancer Society, in January 2024, their "Cancer Statistics, 2024" report indicated nearly 3% of individuals under 50 diagnosed with colorectal cancer attributed their condition to family history or genetic factors, highlighting the need for individualized screening. Guardant Health, Inc.'s November 2025 report in Current Medical Research and Opinion exemplified this, noting its Shield blood-based screening test achieved 95% patient adherence, showcasing improved compliance with precision diagnostics.

Key Market Players

Abbott Laboratories, Inc.
Beckman Coulter, Inc.
Eiken Chemical Co., Ltd.
Sysmex Corporation
Siemens Healthineers AG
Quest Diagnostics Incorporated
Merck KGaA
Kyowa Kirin Co., Ltd.
Randox Laboratories Ltd.
R-Biopharm AG

Report Scope:

In this report, the Global In-vitro Colorectal Cancer Screening Tests Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In-vitro Colorectal Cancer Screening Tests Market, By Test Type:

Fecal Occult Blood Tests
Biomarker tests
CRC DNA Screening Tests

In-vitro Colorectal Cancer Screening Tests Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global In-vitro Colorectal Cancer Screening Tests Market.

Available Customizations:

Global In-vitro Colorectal Cancer Screening Tests Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In-vitro Colorectal Cancer Screening Tests Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Test Type (Fecal Occult Blood Tests, Biomarker tests, CRC DNA Screening Tests)
- 5.2.2. By Region
- 5.2.3. By Company (2024)
5.3. Market Map

6. North America In-vitro Colorectal Cancer Screening Tests Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Test Type
- 6.2.2. By Country
6.3. North America: Country Analysis
- 6.3.1. United States In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Test Type
- 6.3.2. Canada In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Test Type
- 6.3.3. Mexico In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Test Type

7. Europe In-vitro Colorectal Cancer Screening Tests Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Test Type
- 7.2.2. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Test Type
- 7.3.2. France In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Test Type
- 7.3.3. United Kingdom In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Test Type
- 7.3.4. Italy In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Test Type
- 7.3.5. Spain In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Test Type

8. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Test Type
- 8.2.2. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Test Type
- 8.3.2. India In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Test Type
- 8.3.3. Japan In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Test Type
- 8.3.4. South Korea In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Test Type
- 8.3.5. Australia In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Test Type

9. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Test Type
- 9.2.2. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Test Type
- 9.3.2. UAE In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Test Type
- 9.3.3. South Africa In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Test Type

10. South America In-vitro Colorectal Cancer Screening Tests Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Test Type
- 10.2.2. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Test Type
- 10.3.2. Colombia In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Test Type
- 10.3.3. Argentina In-vitro Colorectal Cancer Screening Tests Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Test Type

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global In-vitro Colorectal Cancer Screening Tests Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Abbott Laboratories, Inc.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Beckman Coulter, Inc.
15.3. Eiken Chemical Co., Ltd.
15.4. Sysmex Corporation
15.5. Siemens Healthineers AG
15.6. Quest Diagnostics Incorporated
15.7. Merck KGaA
15.8. Kyowa Kirin Co., Ltd.
15.9. Randox Laboratories Ltd.
15.10. R-Biopharm AG

한글목차

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 체외 대장암 스크리닝 검사 시장 전망

제6장 북미의 체외 대장암 스크리닝 검사 시장 전망

제7장 유럽의 체외 대장암 스크리닝 검사 시장 전망

제8장 아시아태평양의 체외 대장암 스크리닝 검사 시장 전망

제9장 중동 및 아프리카의 체외 대장암 스크리닝 검사 시장 전망

제10장 남미의 체외 대장암 스크리닝 검사 시장 전망

제11장 시장 역학

제12장 시장 동향과 발전

제13장 세계의 체외 대장암 스크리닝 검사 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

제15장 경쟁 구도

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항